News Euro VCs team up to invigorate life sciences ecosystem Major venture capital groups in Europe have joined forces to set up a new coalition aimed at revitalising access to life sciences investment.
Market Access European biopharma at a crossroads If Europe can bridge its operational gaps while leveraging its scientific base, it can carve out a distinctive and sustainable leadership position.
Digital Cracking the code: How European biotechs can win in the US m... At Frontiers Health 2025, Mike Ryan, General Manager Europe at EVERSANA, tackled one of the most pressing questions for emerging pharma and biotech...
R&D How Europe can harness the full potential of biosimilars Biosimilars - clinically equivalent alternatives to original biologic drugs - play a vital role in addressing unmet health needs.
Sales & Marketing Tariffs, pharma, and patients: A Q&A with Orr Inbar In order to discuss the current unsettled landscape, and just how tariffs might affect patients, pharmaphorum spoke with Orr Inbar of QuantHealth.
R&D No longer the little fish: How Europe is holding its own thr... It goes without saying that we are living in uncertain times, yet, this holds particularly true for the pharmaceutical industry.
News Lundbeck preps for key bexicaserin data around year-end Lundbeck has completed patient randomisation in a pivotal trial of epilepsy candidate bexicaserin, one of its major growth hopes.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.